Aristo Bio-Tech & Lifescience Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
Top 10 Fertilizers & Agrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Aristo Bio-Tech & Lifescience Ltd Q2 FY27 key numbers
- Revenue
- Other income was Rs. 15.94 lakh versus Rs. 8.61 lakh for the same period last year.
As stated in Aristo Bio-Tech & Lifescience Ltd's Q2 FY27 results statement · published 15 Nov 2026. Reported figures, not investment advice.
Based on Aristo Bio-Tech & Lifescience Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from operations for the half year ended 30th September 2026 was Rs. 19,824.17 lakh, compared to Rs. 25,645.31 lakh for the half year ended 30th September 2025, indicating a year-on-year decrea. EBITDA for the quarter ended September 30, 2026: Rs. 1,168.88 lakh (calculated as Profit Before Tax + Tax + Finance Cost + Depreciation = 659.84 + 169.65 + 175.57 + 157.33), showing a YoY change com.
From Aristo Bio-Tech & Lifescience Ltd's Q2 FY27 earnings-call transcript · updated 15 Nov 2026.
How did Aristo Bio-Tech & Lifescience's revenue grow in the September 2026 quarter?
- Revenue from operations for the half year ended 30th September 2026 was Rs. 19,824.17 lakh, compared to Rs. 25,645.31 lakh for the half year ended 30th September 2025, indicating a year-on-year decrease.
- Other income was Rs. 15.94 lakh versus Rs. 8.61 lakh for the same period last year.
- Total revenue (operations plus other income) for the half year ended 30th September 2026 was Rs. 19,840.11 lakh, down from Rs. 25,653.93 lakh a year ago.
What happened to Aristo Bio-Tech & Lifescience's margins in Q2 FY27?
EBITDA for the quarter ended September 30, 2026: Rs. 1,168.88 lakh (calculated as Profit Before Tax + Tax…
Locked: what Aristo Bio-Tech & Lifescience Ltd said on margins
Also locked on this page: capex, fundraising, order book
Free account, 30 seconds. No card needed.
What capex is Aristo Bio-Tech & Lifescience planning?
See what Aristo Bio-Tech & Lifescience Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Aristo Bio-Tech & Lifescience raising money or cutting debt?
"Increase in share capital (IPO)" and "Security Premium (IPO)" rows show nil.
Locked: what Aristo Bio-Tech & Lifescience Ltd said on fundraising
Also locked on this page: margins, capex, order book
Free account, 30 seconds. No card needed.
How big is Aristo Bio-Tech & Lifescience's order book?
See what Aristo Bio-Tech & Lifescience Ltd said on order book & pipeline — free account, 30 seconds.
More Q2 FY27 results in Fertilizers & Agrochemicals
- Coromandel Inter Q2 FY27 resultsRevenue ₹10,294 Cr · PAT ₹523 Cr
- UPL Q2 FY27 resultsRevenue ₹11,860 Cr
- P I Industries Q2 FY27 results
- Sumitomo Chemical India Q2 FY27 results
- Chambal Fertilisers & Chemicals Q2 FY27 results
- Paradeep Phosphates Q2 FY27 results
- Madhya Bharat Agro Products Q2 FY27 resultsRevenue ₹715 Cr · PAT ₹78 Cr
- Krishana Phoschem Q2 FY27 results
Continue your research
Others in Fertilizers & Agrochemicals this season
- Madhya Bharat Agro Products (Q2 FY27)
Q2 FY27 Revenue: ₹715 crore, up 59% YoY (Page 12, Chairman’s Quote) . Key investor presentation takeaways from Madhya Bharat Agro Products Ltd's Q2 FY27 investo
- Dhansa Labs (Q2 FY27)
1,864 crores during H1 FY27. Key results statement takeaways from Dhansa Labs Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Krishana Phoschem (Q2 FY27)
Year-on-year revenue growth: Rs 70,254.28 Lakhs vs Rs 60,786.41 Lakhs (~15.6% increase) . Key results statement takeaways from Krishana Phoschem Ltd's Q2 FY27 e
- Balaji Phosphates (Q2 FY27)
Year-on-year growth for the half year (Standalone): ~31.4% increase (from Rs. Key results statement takeaways from Balaji Phosphates Ltd's Q2 FY27 results state
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Insecticides IndiaGood growth2
- Anya Polytech &Good growth1
- Madhya Bharat Agro ProductsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Aristo Bio-Tech & Lifescience Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Aristo Bio-Tech & Lifescience Ltd Q2 FY27 results?
Revenue from operations for the half year ended 30th September 2026 was Rs. 19,824.17 lakh, compared to Rs. 25,645.31 lakh for the half year ended 30th September 2025, indicating a year-on-year decrea. EBITDA for the quarter ended September 30, 2026: Rs. 1,168.88 lakh (calculated as Profit Before Tax + Tax + Finance Cost + Depreciation = 659.84 + 169.65 + 175.57 + 157.33), showing a YoY change com.
What is Aristo Bio-Tech & Lifescience Ltd share price analysis?
Aristo Bio-Tech & Lifescience Ltd currently shows a neutral. The stock trades at a P/E of 11.2 with a market cap of ₹80 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Aristo Bio-Tech & Lifescience Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
